Starnac P 100 mg/500 mg Tablet
By Starnac P
Rx
10 Tablet in a Strip

Composition
Aceclofenac(100mg) + Paracetamol(500mg)

Manufacturer - Invision Medi Sciences Pvt Ltd
Invision Medi Sciences Pvt. Ltd, New No.3, Old No.231, 12th Cross, Wilson Garden, Bangalore

Expires on or after
July, 2025

liver
Caution is advised when using Starnac P 100 mg/500 mg Tablet in patients with liver disease. It may be necessary to adjust the dosage of the tablet in such cases, so it is important to consult with your doctor before starting or continuing with this medication. However, it is not recommended to use Starnac P 100 mg/500 mg Tablet in patients with severe liver disease or active liver disease. It is crucial to prioritize your liver health and seek guidance from a healthcare professional regarding the use of this medication.

kidney
Starnac P 100 mg/500 mg Tablet should be used carefully in patients with kidney disease as dose adjustment may be necessary. It is not recommended for those with severe kidney disease. Please consult your doctor for proper guidance.

alcohol
It is unsafe to consume alcohol with Starnac P 100 mg/500 mg Tablet. Alcohol may interact negatively with the medication, causing potential harm. Avoid alcohol when taking this tablet.

driving
When taking Starnac P 100 mg/500 mg Tablet, be cautious while driving. It may reduce alertness, cause vision changes, drowsiness, or dizziness. Avoid driving if these side effects occur to ensure safety on the road.

pregnancy
Starnac P 100 mg/500 mg Tablet may be unsafe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
It is better to consult your doctor before using Starnac P 100 mg/500 mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹40
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024